711 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by Steel Grove Capital Advisors LLC

Steel Grove Capital Advisors LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 711 shares of the healthcare conglomerate’s stock, valued at approximately $352,000.

Other institutional investors also recently modified their holdings of the company. Sharkey Howes & Javer lifted its holdings in shares of UnitedHealth Group by 3.7% during the 4th quarter. Sharkey Howes & Javer now owns 564 shares of the healthcare conglomerate’s stock worth $297,000 after acquiring an additional 20 shares during the period. Bensler LLC boosted its stake in UnitedHealth Group by 0.3% in the 4th quarter. Bensler LLC now owns 7,313 shares of the healthcare conglomerate’s stock valued at $3,850,000 after buying an additional 20 shares in the last quarter. Legend Financial Advisors Inc. lifted its holdings in shares of UnitedHealth Group by 27.4% during the fourth quarter. Legend Financial Advisors Inc. now owns 93 shares of the healthcare conglomerate’s stock valued at $49,000 after acquiring an additional 20 shares during the period. Veracity Capital LLC grew its holdings in shares of UnitedHealth Group by 1.5% in the 1st quarter. Veracity Capital LLC now owns 1,335 shares of the healthcare conglomerate’s stock worth $660,000 after purchasing an additional 20 shares during the last quarter. Finally, Rodgers Brothers Inc. grew its stake in UnitedHealth Group by 2.4% during the first quarter. Rodgers Brothers Inc. now owns 842 shares of the healthcare conglomerate’s stock worth $417,000 after buying an additional 20 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Stock Up 1.8 %

NYSE:UNH traded up $10.04 during trading hours on Friday, reaching $569.72. 3,202,023 shares of the stock were exchanged, compared to its average volume of 5,159,030. The firm has a 50 day moving average of $508.82 and a 200 day moving average of $501.45. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.85. The stock has a market cap of $524.36 billion, a PE ratio of 34.82, a PEG ratio of 1.59 and a beta of 0.60. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $581.50.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. The firm had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the previous year, the firm posted $6.14 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were issued a dividend of $2.10 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date was Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.47%. UnitedHealth Group’s payout ratio is presently 51.34%.

Analyst Ratings Changes

Several equities analysts have issued reports on UNH shares. UBS Group lifted their price objective on UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a research report on Thursday, July 18th. Royal Bank of Canada raised their price target on shares of UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Barclays lifted their target price on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, July 19th. Finally, JPMorgan Chase & Co. boosted their price target on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. One research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.